Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Equity Financing Program	Optogration, Inc.	ECARX Holdings, Inc. (ECX)	Freedom Photonics	Solfice	TPK Universal Solutions Limited	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Equity Financing Program	Additional Paid-in Capital Optogration, Inc.	Additional Paid-in Capital ECARX Holdings, Inc. (ECX)	Additional Paid-in Capital Freedom Photonics	Additional Paid-in Capital Solfice	Additional Paid-in Capital TPK Universal Solutions Limited	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Equity Financing Program	Class A Common Stock Common Stock	Class A Common Stock Common Stock Equity Financing Program	Class A Common Stock Common Stock Optogration, Inc.	Class A Common Stock Common Stock ECARX Holdings, Inc. (ECX)	Class A Common Stock Common Stock Freedom Photonics	Class A Common Stock Common Stock Solfice	Class A Common Stock Common Stock TPK Universal Solutions Limited	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020																					218,818,037								105,118,203
Beginning balance at Dec. 31, 2020	$ 148,741								$ 733,175							$ 34	$ 0	$ (584,501)			$ 22								$ 11
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchases of capped call options related to the convertible senior notes	(73,438)								(73,438)
Shares repurchased																	(235,871)
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)																					15,574,037
Issuance of Class A common stock upon exercise of Public and Private Warrants	492,221								492,219												$ 2
Issuance of Class A common stock (in Shares)																					5,232,744
Issuance of Class A common stock	6,176								6,176
Retirement of unvested restricted common stock (in shares)																					(71,894)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)																					291,940
Vendor payments under the stock-in-lieu of cash program	10,743								10,743
Acquisition (in shares)																							370,034
Acquisitions			$ 6,527								$ 6,527
Issuance of earn-out shares (in shares)																					10,242,703								6,970,467
Issuance of earn-out shares	0								(2)												$ 1								$ 1
Issuance of shares for investment in Robotic Research Opco, LLC (in shares)																					618,924
Issuance of shares for investment in Robotic Research Opco, LLC	10,002								10,002
Conversion of Class B common stock into Class A common stock (in shares)																					15,000,000								(15,000,000)
Conversion of Class B common stock into Class A common stock	0																				$ 2								$ (2)
Stock-based compensation	70,983								70,983
Expense related to Volvo Warrants	959
Payments of employee taxes related to vested restricted stock units/ stock-based awards	(140)								(140)
Cash received from Gores on settlement of recapitalization of escrow	10								10
Other comprehensive income (loss)	(942)															(942)
Net loss	(237,986)																	(237,986)
Ending balance (in shares) at Dec. 31, 2021																					266,076,525								97,088,670
Ending balance at Dec. 31, 2021	197,985								1,257,214							(908)	(235,871)	(822,487)			$ 27								$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(76,606)																(76,606)
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)																					405,752
Issuance of Class A common stock upon exercise of Public and Private Warrants	19,003								19,003
Issuance of Class A common stock (in Shares)																					9,177,748
Issuance of Class A common stock	3,945								3,944												$ 1
Issuance of Class A common stock under ESPP (in shares)																					168,147
Issuance of Class A common stock under ESPP	1,271								1,271
Retirement of unvested restricted common stock (in shares)																			(6,599,689)		(48,298)
Vendor payments under the stock-in-lieu of cash program (in shares)																					9,949,385
Vendor payments under the stock-in-lieu of cash program	80,255								80,254												$ 1
Investment in ECARX Holdings, Inc. (in shares)																								2,030,374
Investment in ECARX Holdings, Inc.				$ 12,588								$ 12,588
Optogration milestone awards (in shares)																					1,632,056
Optogration milestone awards	11,751								11,751
Acquisition (in shares)																									2,176,205	374,193
Acquisitions					$ 30,510	$ 3,361							$ 30,510	$ 3,361
Stock-based compensation	142,519								142,519
Payments of employee taxes related to vested restricted stock units/ stock-based awards	(3,730)								(3,730)
Other comprehensive income (loss)	(3,318)															(3,318)
Net loss	(445,939)																	(445,939)
Ending balance (in shares) at Dec. 31, 2022																			270,078,637		291,942,087							97,088,670	97,088,670
Ending balance at Dec. 31, 2022	(26,405)								1,558,685							(4,226)	(312,477)	(1,268,426)			$ 29								$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock (in Shares)																					18,636,245	9,467,996					3,305,784
Issuance of Class A common stock	3,056	$ 50,190					$ 20,000		3,054	$ 50,189					$ 20,000					$ 50,200	$ 2	$ 1
Issuance of Class A common stock under ESPP (in shares)																					707,258
Issuance of Class A common stock under ESPP	2,641								2,641
Issuance of Class A common stock to Plus AI (in shares)								1,926,471
Issuance of Class A common stock to Plus AI	12,141								12,141
Vendor payments under the stock-in-lieu of cash program (in shares)																					15,676,862
Vendor payments under the stock-in-lieu of cash program	75,873								75,871												$ 2
Milestone awards relating to acquisitions (in shares)																					2,943,401
Milestone awards relating to acquisitions	20,656								20,656
Stock-based compensation	186,278								186,278
Payments of employee taxes related to vested restricted stock units/ stock-based awards	(2,137)								(2,137)
Other comprehensive income (loss)	4,228															4,228
Net loss	(571,269)																	(571,269)
Ending balance (in shares) at Dec. 31, 2023																			322,742,654		344,606,104							97,088,670	97,088,670
Ending balance at Dec. 31, 2023	$ (224,748)								$ 1,927,378							$ 2	$ (312,477)	$ (1,839,695)			$ 34								$ 10